Form 4: Johnson & Johnson Executive VP Elizabeth Forminard Reports Stock Transactions
SEC Form 4 Filing
Executive VP and General Counsel of Johnson & Johnson, Elizabeth Forminard, reports multiple transactions involving common stock and restricted/performance share units.
Summary
- Elizabeth Forminard, Executive VP and General Counsel of Johnson & Johnson, filed a Form 4 detailing changes in beneficial ownership.
- The reported transactions include the vesting of Restricted Share Units (RSUs) and Performance Share Units (PSUs) awarded under the company's Long-Term Incentive Plan.
- These units convert into shares of Johnson & Johnson common stock upon vesting.
- Shares were also withheld for payment of taxes upon the vesting of RSUs and PSUs.
- The transactions occurred between February 13, 2025, and February 18, 2025.
- Following the reported transactions, Forminard beneficially owns 10,902 shares of common stock and 1,922 Restricted Share Units.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions, with neutral sentiment.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors.
Comparison to Industry Standards
- Executive compensation packages at Johnson & Johnson, including RSUs and PSUs, are likely benchmarked against peer companies in the pharmaceutical and healthcare industries.
- Companies like Pfizer, Merck, and AbbVie also utilize similar long-term incentive plans to align executive interests with shareholder value.
- The vesting schedules and performance metrics associated with these units are typically designed to be competitive within the industry.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they represent routine executive compensation activities.
- Shareholders may be interested in the details of executive compensation and insider transactions for insights into management's alignment with company performance.
Key Dates
| Date | Description |
|---|---|
| 02/13/2023 | Date of RSU award that vests in three annual equal installments beginning on the first anniversary of the grant date. |
| 02/14/2022 | Date of RSU and PSU awards that vest three years after the date of grant. |
| 02/15/2024 | Date of RSU award that vests in three annual equal installments beginning on the first anniversary of the grant date. |
| 02/13/2025 | Transaction date for RSU vesting. |
| 02/14/2025 | Transaction date for RSU and PSU vesting, and shares withheld for taxes. |
| 02/15/2025 | Transaction date for RSU vesting. |
| 02/18/2025 | Transaction date for shares withheld for taxes. |
Keywords
Form 4, beneficial ownership, Elizabeth Forminard, Johnson & Johnson, JNJ, restricted share units, performance share units, stock transactions, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.